| pubmed-article:16505423 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16505423 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:16505423 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:16505423 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:16505423 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:16505423 | lifeskim:mentions | umls-concept:C1518419 | lld:lifeskim |
| pubmed-article:16505423 | lifeskim:mentions | umls-concept:C0593802 | lld:lifeskim |
| pubmed-article:16505423 | lifeskim:mentions | umls-concept:C0332152 | lld:lifeskim |
| pubmed-article:16505423 | lifeskim:mentions | umls-concept:C0935916 | lld:lifeskim |
| pubmed-article:16505423 | lifeskim:mentions | umls-concept:C0449258 | lld:lifeskim |
| pubmed-article:16505423 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:16505423 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:16505423 | pubmed:dateCreated | 2006-2-28 | lld:pubmed |
| pubmed-article:16505423 | pubmed:abstractText | Fulvestrant is an antiestrogen that leads to estrogen receptor degradation and has demonstrated efficacy in breast cancer patients who have had disease recurrence or progression after tamoxifen. This study was designed to examine the efficacy and toxicity of fulvestrant in patients with disease progression on a third-generation aromatase inhibitor (AI). | lld:pubmed |
| pubmed-article:16505423 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16505423 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16505423 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16505423 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16505423 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:16505423 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:16505423 | pubmed:author | pubmed-author:PerezEdith... | lld:pubmed |
| pubmed-article:16505423 | pubmed:author | pubmed-author:IngleJames... | lld:pubmed |
| pubmed-article:16505423 | pubmed:author | pubmed-author:CamorianoJohn... | lld:pubmed |
| pubmed-article:16505423 | pubmed:author | pubmed-author:SumanVera JVJ | lld:pubmed |
| pubmed-article:16505423 | pubmed:author | pubmed-author:RowlandKendri... | lld:pubmed |
| pubmed-article:16505423 | pubmed:author | pubmed-author:NikcevichDani... | lld:pubmed |
| pubmed-article:16505423 | pubmed:author | pubmed-author:MirchandaniDe... | lld:pubmed |
| pubmed-article:16505423 | pubmed:author | pubmed-author:BernathAlbert... | lld:pubmed |
| pubmed-article:16505423 | pubmed:author | pubmed-author:FishkinPaul... | lld:pubmed |
| pubmed-article:16505423 | pubmed:author | pubmed-author:North... | lld:pubmed |
| pubmed-article:16505423 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:16505423 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:16505423 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:16505423 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16505423 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16505423 | pubmed:pagination | 1052-6 | lld:pubmed |
| pubmed-article:16505423 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:16505423 | pubmed:meshHeading | pubmed-meshheading:16505423... | lld:pubmed |
| pubmed-article:16505423 | pubmed:meshHeading | pubmed-meshheading:16505423... | lld:pubmed |
| pubmed-article:16505423 | pubmed:meshHeading | pubmed-meshheading:16505423... | lld:pubmed |
| pubmed-article:16505423 | pubmed:meshHeading | pubmed-meshheading:16505423... | lld:pubmed |
| pubmed-article:16505423 | pubmed:meshHeading | pubmed-meshheading:16505423... | lld:pubmed |
| pubmed-article:16505423 | pubmed:meshHeading | pubmed-meshheading:16505423... | lld:pubmed |
| pubmed-article:16505423 | pubmed:meshHeading | pubmed-meshheading:16505423... | lld:pubmed |
| pubmed-article:16505423 | pubmed:meshHeading | pubmed-meshheading:16505423... | lld:pubmed |
| pubmed-article:16505423 | pubmed:meshHeading | pubmed-meshheading:16505423... | lld:pubmed |
| pubmed-article:16505423 | pubmed:meshHeading | pubmed-meshheading:16505423... | lld:pubmed |
| pubmed-article:16505423 | pubmed:meshHeading | pubmed-meshheading:16505423... | lld:pubmed |
| pubmed-article:16505423 | pubmed:meshHeading | pubmed-meshheading:16505423... | lld:pubmed |
| pubmed-article:16505423 | pubmed:meshHeading | pubmed-meshheading:16505423... | lld:pubmed |
| pubmed-article:16505423 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16505423 | pubmed:articleTitle | Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032. | lld:pubmed |
| pubmed-article:16505423 | pubmed:affiliation | Division of Medical Oncology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA. ingle.james@mayo.edu | lld:pubmed |
| pubmed-article:16505423 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16505423 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:16505423 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| pubmed-article:16505423 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16505423 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16505423 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16505423 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16505423 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16505423 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16505423 | lld:pubmed |
